MedPath

VISTASEAL

VISTASEAL

Approved
DIN Number

02514257

Drug Class

Human

Market Date

Feb 16, 2022

Company
HC

INSTITUTO GRIFOLS SA

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02514257
AIG Number0252708002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
B02BC30 COMBINATIONS
Product Specifications
Dosage FormSolution
Route of AdministrationTopical
AHFS Classification20:28.16
Health Canada Classification

ACTIVE INGREDIENTS (2)

FIBRINOGEN (HUMAN)Active
Strength: 400 MG / 5 ML
Monograph: FIBRINOGEN (HUMAN)
THROMBIN (HUMAN)Active
Strength: 2500 UNIT / 5 ML
Monograph: THROMBIN (HUMAN)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.